000			01369 a2200373 4500
005			20250515035529.0
264		0	_c20060912
008			200609s 0 0 eng d
022			_a1468-201X
024	7		_a10.1136/hrt.2005.083006 _2doi
040			_aNLM _beng _cNLM
100	1		_aHarding, S A
245	0	0	_aClopidogrel reduces platelet-leucocyte aggregation, monocyte activation and RANTES secretion in type 2 diabetes mellitus. _h[electronic resource]
260			_bHeart (British Cardiac Society) _cSep 2006
300			_a1335-7 p. _bdigital
500			_aPublication Type: Letter; Research Support, Non-U.S. Gov't
650	0	4	_aChemokine CCL5 _xmetabolism
650	0	4	_aClopidogrel
650	0	4	_aDiabetes Mellitus, Type 2 _xblood
650	0	4	_aHumans
650	0	4	_aLeukocytes, Mononuclear _xdrug effects
650	0	4	_aLymphocyte Activation _xdrug effects
650	0	4	_aMiddle Aged
650	0	4	_aPlatelet Aggregation _xdrug effects
650	0	4	_aPlatelet Aggregation Inhibitors _xpharmacology
650	0	4	_aTiclopidine _xanalogs & derivatives
700	1		_aSarma, J
700	1		_aDin, J N
700	1		_aMaciocia, P M
700	1		_aNewby, D E
700	1		_aFox, K A A
773	0		_tHeart (British Cardiac Society) _gvol. 92 _gno. 9 _gp. 1335-7
856	4	0	_uhttps://doi.org/10.1136/hrt.2005.083006 _zAvailable from publisher's website
999			_c16496010 _d16496010